Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Front-line”

203 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 203 results

Not applicableUnknownNCT04904380
What this trial is testing

Impact of New Tools of Simulation-enhanced Peer Learning on Neonatal and Maternal Mortality

Who this might be right for
Neonatal MortalityMaternal Mortality
Mbarara University of Science and Technology 3,456
Large-scale testing (Phase 3)Study completedNCT00046683
What this trial is testing

Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients With Progressive B-Cell Lymphocytic Leukemia

Who this might be right for
B Cell Chronic Lymphocytic Leukemia
Genzyme, a Sanofi Company 284
Testing effectiveness (Phase 2)Active Not RecruitingNCT04416451
What this trial is testing

A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
Memorial Sloan Kettering Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT02370238
What this trial is testing

Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Dompé Farmaceutici S.p.A 194
Testing effectiveness (Phase 2)Looking for participantsNCT05098132
What this trial is testing

Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerUntreated Advanced NSCLC+1 more
Synthekine 364
Not applicableEnded earlyNCT00663819
What this trial is testing

Bioabsorbable Staple Line Reinforcement in Colorectal,Coloanal and Ileoanal Anastomoses

Who this might be right for
Rectal CancerUlcerative ColitisFamilial Adenomatous Polyposis+1 more
W.L.Gore & Associates 258
Early research (Phase 1)Study completedNCT03245892
What this trial is testing

Carboplatin and Paclitaxel Chemotherapy With Nivolumab With or Without Ipilimumab in Patients With Ovarian Cancer

Who this might be right for
High Grade Serous OvarianFallopian TubePrimary Peritoneal Cancer
Memorial Sloan Kettering Cancer Center 27
Testing effectiveness (Phase 2)Study completedNCT00061477
What this trial is testing

Pemetrexed Plus Gemcitabine as Front-Line Chemotherapy for Patients With Malignant Pleural or Peritoneal Mesothelioma

Who this might be right for
Mesothelioma
Eli Lilly and Company 48
Testing effectiveness (Phase 2)Ended earlyNCT00086632
What this trial is testing

Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment

Who this might be right for
Ovarian Cancer
Unither Pharmaceuticals 40
Not applicableNot Yet RecruitingNCT06962176
What this trial is testing

Posterior Mitral Isthmus Line With Vein of Marshall Ethanolisation Compared With Anterior Mitral Lines in Patients With Persistent Atrial Fibrillation

Who this might be right for
Persistent Atrial Fibrillation
AZ Sint-Jan AV 146
Testing effectiveness (Phase 2)UnknownNCT01990144
What this trial is testing

Rituximab Plus Bendamustine as Front Line Treatment in Frail Elderly (>70 Years) Patients With DLBCL: a Phase II Multicenter Study of the FIL

Who this might be right for
Diffuse Large B-cell Lymphoma
Fondazione Italiana Linfomi - ETS 49
Large-scale testing (Phase 3)Study completedNCT00676507
What this trial is testing

Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy

Who this might be right for
Lung NeoplasmCarcinoma Non-small Cell Lung Cancer Stage IIIACarcinoma Non-small Cell Lung Cancer Stage IIIB+1 more
NovaRx Corporation 532
Large-scale testing (Phase 3)Temporarily pausedNCT00892346
What this trial is testing

Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma

Who this might be right for
Multiple Myeloma
Shanghai Jiao Tong University School of Medicine 80
Early research (Phase 1)Study completedNCT00814086
What this trial is testing

Cisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer

Who this might be right for
Chemotherapeutic Agent ToxicityEndometrial AdenocarcinomaFallopian Tube Carcinoma+12 more
Gynecologic Oncology Group 23
Large-scale testing (Phase 3)Study completedNCT00866203
What this trial is testing

HDS Plus PBPC Transplant Vs 4 More Courses of FrontLine Therapy in Pts With Aggressive NHL in PR After Induction Therapy

Who this might be right for
High-Grade Lymphomas
Gruppo Italiano Studio Linfomi 441
Testing effectiveness (Phase 2)Active Not RecruitingNCT05388123
What this trial is testing

Low Dose Vemurafenib and Rituximab in Hairy Cell Leukemia

Who this might be right for
Hairy Cell Leukemia
Scripps Health 20
Testing effectiveness (Phase 2)Study completedNCT02649387
What this trial is testing

Ibrutinib in Treating Minimal Residual Disease in Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy

Who this might be right for
Stage I Chronic Lymphocytic LeukemiaStage II Chronic Lymphocytic LeukemiaStage III Chronic Lymphocytic Leukemia+1 more
Mayo Clinic 35
Testing effectiveness (Phase 2)Study completedNCT00061464
What this trial is testing

Pemetrexed Plus Gemcitabine for Patients With Locally Advanced or Metastatic NSCLC Who Have Not Had Previous Chemotherapy.

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 48
Testing effectiveness (Phase 2)Study completedNCT00006351
What this trial is testing

SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
European Organisation for Research and Treatment of Cancer - EORTC 34
Large-scale testing (Phase 3)Study completedNCT03939637
What this trial is testing

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Who this might be right for
Immune Thrombocytopenia
Baylor College of Medicine 122
Load More Results